Mansour F. Armaly
Mansour F. Armaly was a pioneering figure in the field of ophthalmology, particularly known for his contributions to the understanding and treatment of glaucoma. Born in Palestine, Armaly made significant strides in the medical field, impacting both clinical practices and research methodologies.
Early Life and Education[edit | edit source]
Mansour F. Armaly was born in Palestine in the early 20th century. He pursued his medical education with a focus on ophthalmology, recognizing early on the importance of specialized research in advancing medical care and treatment options for eye diseases.
Career and Contributions[edit | edit source]
Throughout his career, Armaly focused on the study of glaucoma, a group of eye conditions that can cause blindness by damaging the optic nerve, usually due to high eye pressure. He is best known for his work on the effects of steroids on intraocular pressure, a key factor in the development and management of glaucoma. His research provided groundbreaking insights into how steroids influence eye pressure and the implications for treating patients with glaucoma.
Armaly's work extended beyond the clinical implications of his research. He was instrumental in developing methodologies for the early detection and management of glaucoma, including the Armaly Glaucoma Screening Test. This test was a significant advancement in the field, allowing for earlier detection of glaucoma and, consequently, more effective management of the condition.
In addition to his research, Armaly was a dedicated educator, sharing his knowledge and expertise with future generations of ophthalmologists. He held several academic positions, where he was able to influence the field of ophthalmology through both his teaching and his research.
Legacy[edit | edit source]
Mansour F. Armaly's contributions to the field of ophthalmology have left a lasting legacy. His work on the effects of steroids on intraocular pressure and the development of screening methods for glaucoma have had a profound impact on the treatment and management of the disease. Today, his research continues to influence the field, guiding both clinical practices and ongoing research in ophthalmology.
See Also[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD